MONTREAL, QUEBEC--(MARKET WIRE)--Sep 5, 2007 -- ART Advanced Research Technologies Inc. (“ART”) (Toronto:ARA.TO - News), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that a collaboration agreement has been signed with the National Research Council of Canada’s Institute for Biological Sciences (“NRC-IBS”) for the development of client-oriented diagnostic applications using the Company’s proprietary time domain technology, in the emerging discipline of molecular imaging.
